World Health Organization. WHO COVID-19 Dashboard. Accessed February 7, 2024. https://covid19.who.int/

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

International Diabetes Federation. IDF Diabetes Atlas. 10th ed (2021). Accessed 23 May 2022. Available from https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36:e3319. https://doi.org/10.1002/dmrr.3319.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14:303–10. https://doi.org/10.1016/j.dsx.2020.04.004.

Article  PubMed  PubMed Central  Google Scholar 

Piperi C, Goumenos A, Adamopoulos C, Papavassiliou AG. AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential. Int J Biochem Cell Biol. 2015;60:197–201. https://doi.org/10.1016/j.biocel.2015.01.009.

Article  CAS  PubMed  Google Scholar 

Mosquera-Sulbarán JA, Hernández-Fonseca JP. Advanced glycation end products in diabetes. In: Patel VB, Preedy VR, editors. Biomarkers in diabetes, biomarkers in disease: methods, discoveries and applications. Springer Nature Switzerland; 2023. p. 171–94. https://doi.org/10.1007/978-3-031-08014-2_8.

Chapter  Google Scholar 

Du C, Whiddett RO, Buckle I, Chen C, Forbes JM, Fotheringham AK. Advanced glycation end products and inflammation in type 1 diabetes development. Cells. 2022;11:3503. https://doi.org/10.3390/cells11213503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angioni R, Bonfanti M, Caporale N, Sánchez-Rodríguez R, Munari F, Savino A, Pasqualato S, Buratto D, Pagani I, Bertoldi N, Zanon C, Ferrari P, Ricciardelli E, Putaggio C, Ghezzi S, Elli F, Rotta L, Scardua A, Weber J, Cecatiello V, Iorio F, Zonta F, Cattelan AM, Vicenzi E, Vannini A, Molon B, Villa CE, Viola A, Testa G. RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity. Cell Rep Med. 2023;4:101266. https://doi.org/10.1016/j.xcrm.2023.101266.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia J, Wang J, Ying L, Huang R, Zhang K, Zhang R, Tang W, Xu Q, Lai D, Zhang Y, Hu Y, Zhang X, Zang R, Fan J, Shu Q, Xu J. RAGE is a receptor for SARS-CoV-2 N protein and mediates N protein-induced acute lung injury. Am J Respir Cell Mol Biol. 2023;69:508–20. https://doi.org/10.1165/rcmb.2022-0351OC.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutowska K, Czajkowski K, Kuryłowicz A. Receptor for the advanced glycation end products (RAGE) pathway in adipose tissue metabolism. Int J Mol Sci. 2023;24:10982. https://doi.org/10.3390/ijms241310982.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mosquera JA. Role of the receptor for advanced glycation end products (RAGE) in inflammation. Invest Clin. 2010;51:257–68.

PubMed  Google Scholar 

Ibrahim ZA, Armour CL, Phipps S, Sukkar MB. RAGE and TLRs: Relatives, friends or neighbours? Mol Immunol. 2013;56:739–44. https://doi.org/10.1016/j.molimm.2013.07.008.

Article  CAS  PubMed  Google Scholar 

Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways. Arch Biochem Biophys. 2019;670:4–14. https://doi.org/10.1016/j.abb.2019.02.008.

Article  CAS  PubMed  Google Scholar 

Zhu Y, Deng J, Nan ML, Zhang J, Okekunle A, Li JY, Yu XQ, Wang PH. The interplay between pattern recognition receptors and autophagy in inflammation. Adv Exp Med Biol. 2019;1209:79–108. https://doi.org/10.1007/978-981-15-0606-2_6.

Article  CAS  PubMed  Google Scholar 

Brett J, Schmidt AM, Yan SD, Zhou YS, Weidmann E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Dhaw A, Migheli A, Stern DM. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissue. Am J Pathol. 1993;143:1699–712.

CAS  PubMed  PubMed Central  Google Scholar 

Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876–86. https://doi.org/10.1007/s00109-005-0688-7.

Fehrenbach H, Kasper M, Tschernig T, Shearman MS, Schuh D, Müller M. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand). 1998;44:1147–57.

Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312. https://doi.org/10.3390/cells11081312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue Q, Song Y, Liu Z, Zhang L, Yang L, Li J. Receptor for advanced glycation end products (RAGE): a pivotal hub in immune diseases. Molecules. 2022;27:4922. https://doi.org/10.3390/molecules27154922.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chellappa RC, Palanisamy R, Swaminathan K. RAGE isoforms, its ligands and their role in pathophysiology of Alzheimer’s disease. Curr Alzheimer Res. 2020;17:1262–79. https://doi.org/10.2174/156.

Article  CAS  PubMed  Google Scholar 

Palanissami G, Paul SFD. RAGE and its ligands: molecular interplay between glycation, inflammation, and hallmarks of cancer-a review. Horm Cancer. 2018;9:295–325. https://doi.org/10.1007/s12672-018-0342-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidt AM, Stern DM. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Front Biosci. 2001;6:D1151–60. https://doi.org/10.2741/Schmidt.

Article  CAS  PubMed  Google Scholar 

Juranek J, Mukherjee K, Kordas B, Załęcki M, Korytko A, Zglejc-Waszak K, Szuszkiewicz J, Banach M. Role of RAGE in the pathogenesis of neurological disorders. Neurosci Bull. 2022;38:1248–62. https://doi.org/10.1007/s12264-022-00878-x.

Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12:542. https://doi.org/10.3390/biom12040542.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen CY, Lu CH, Wu CH, Li KJ, Kuo YM, Hsieh SC, Yu CL. The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases. Molecules. 2020;25:5591. https://doi.org/10.3390/molecules25235591.

Lenga Ma Bonda W, Fournet M, Zhai R, Lutz J, Blondonnet R, Bourgne C, Leclaire C, Saint-Béat C, Theilliere C, Belville C, Bouvier D, Blanchon L, Berger M, Sapin V, Jabaudon M. Receptor for advanced glycation end-products promotes activation of alveolar macrophages through the nlrp3 inflammasome/TXNIP axis in acute lung injury. Int J Mol Sci. 2022;23:11659. https://doi.org/10.3390/ijms231911659.

Killian KN, Kosanovich JL, Lipp MA, Empey KM, Oury TD, Perkins TN. RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice. Front Immunol. 2023;14:1039997. https://doi.org/10.3389/fimmu.2023.1039997.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaidt MM, Hornung V. The NLRP3 inflammasome renders cell death pro-inflammatory. J Mol Biol. 2018;430:133–41. https://doi.org/10.1016/j.jmb.2017.11.013.

Article  CAS  PubMed  Google Scholar 

Sharma M, de Alba E. Structure, activation and regulation of NLRP3 and AIM2 inflammasomes. Int J Mol Sci. 2021;22:872. https://doi.org/10.3390/ijms22020872.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao J, Sterling K, Wang Z, Zhang Y, Song W. The role of inflammasomes in human diseases and their potential as therapeutic targets. Signal Transduct Target Ther. 2024;9:10. https://doi.org/10.1038/s41392-023-01687-y.

Article  PubMed  PubMed Central  Google Scholar